Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |